Literature DB >> 13365474

Clinical and pharmacological effects of substance BZ-55 in diabetes; (p-aminophenylsulfonyl butylcarbamide).

R C ANDERSON, W R KIRTLEY, A S RIDOLFO, M A ROOT.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/therapy; SULFANILAMIDE/related compounds; UREA/related compounds

Mesh：

Substances：

Year:  1956        PMID： 13365474     DOI： 10.2337/diab.5.5.351

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  3 in total

1.  The potentiation of exogenous insulin by tolbutamide in depancreatized dogs.

Authors:  R CAREN; L CORBO
Journal:  J Clin Invest       Date:  1957-11       Impact factor: 14.808

2.  [Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. I. Body weight, carbohydrate metabolism and immunoreactive insulin].

Authors:  A Appels; R Kattermann; H Proschek; K Hubrich; H Frerichs; H D Söling; W Creutzfeldt
Journal:  Diabetologia       Date:  1968-08       Impact factor: 10.122

3.  Experience with tolbutamide (orinase in the management of 100 cases of diabetes.

Authors:  J B McKENDRY; K KUWAYTI; L A SAGLE
Journal:  Can Med Assoc J       Date:  1957-09-01       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.